Biosynthesis and degradation of mammalian glycosphingolipids

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 358, Issue 1433, 2003, Pages 847-861

  Sandhoff, Konrad ^a   Kolter, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Biosynthesis; Glycolipids; Lysosomes; Sphingolipid; Sphingolipid activator proteins

Indexed keywords

LIPID;

ANIMALIA; EUKARYOTA; MAMMALIA;

EID: 0037762571     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2003.1265     Document Type: Conference Paper

References (186)

1. Allende, M. L., Li, J., Darling, D. S., Worth, C. A. & Young Jr, W. W. 2000 Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion. Glycobiol. 10, 1025-1032.
2. Amidon, B., Brown, A. & Waite, M. 1996 Transacylase and phospholipases in the synthesis of bis(monoacylglycero)phosphate. Biochemistry 35, 13 995-14 002.
3. Becker, E. 1999 Magnetic isolation of lysosomes from human fibroblasts. Characterization of the lipid pattern. PhD thesis, Bonn University, Germany.
4. Berent, S. L. & Radin, N. S. 1981 Mechanism of activation of glucocerebrosidase by co-β-glucosidase (glucosidase activator protein). Biochim. Biophys. Acta 664, 572-582.
5. Bieberich, E. & Yu, R. K. 1999 Multi-enzyme kinetic analysis of glycolipid biosynthesis. Biochim. Biophys. Acta 1432, 113-124.
6. Bosio, A., Binczek, E. & Stoffel, W. 1996 Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl Acad. Sci. USA 93, 13 280-13 285.
7. Bradova, V., Smid, F., Ulrich-Bott, B., Roggendorf, W., Paton, B. C. & Harzer, K. 1993 Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum. Genet. 92, 143-152.
8. Braun, P. E. & Snell, E. E. 1968 Biosynthesis of sphingolipid bases. II. Keto intermediates in synthesis of sphingosine and dihydrosphingosine by cell-free extracts of Hansenula ciferri. J. Biol. Chem. 243, 3775-3783.
9. Brotherus, J. & Renkonen, O. 1977 Subcellular distributions of lipids in cultured BHK cells: evidence for the enrichment of lysobisphosphatidic acid and neutral lipids in lysosomes. J. Lipid Res. 18, 191-202.
10. Burkhardt, J. K., Hüttler, S., Klein, A. M., Möbius, W., Habermann, A., Griffiths, G. & Sandhoff, K. 1997 Accumulation of sphingolipids in SAP-precursor (prosaposin) deficient fibroblasts occurs within lysosomes and can be completely reversed by treatment with human SAP-precursor. Eur. J. Cell Biol. 73, 10-18.
11. Carlsson, S. R., Roth, J., Piller, F. & Fukuda, M. 1988 Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. J. Biol. Chem. 263, 18 911-18 919.
12. Chiavegatto, S., Sun, J., Nelson, R. J. & Schnaar, R. L. 2000 A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp. Neurol. 166, 227-234.
13. Chojnacki, T. & Dallner, G. 1988 The biological role of dolichol. Biochem. J. 251, 1-9.
14. Christomanou, H., Aignesberg, A. & Linke, R. P. 1986 Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant. Biol. Chem. Hoppe-Seyler 367, 879-890.
15. Ciaffoni, F., Salvioli, R., Tatti, M., Arancia, G., Crateri, P. & Vaccaro, A. M. 2001 Saposin D solubilizes anionic phospholipid-containing membranes. J. Biol. Chem. 276, 31 583-31 589.
16. Coetzee, T., Fujita, N., Dupree, J., Shi, R., Blight, A., Suzuki, K., Suzuki, K. & Popko, B. 1996 Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86, 209-219.
17. Conzelmann, E. & Sandhoff, K. 1978 AB variant of infantile GM2-gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc. Natl Acad. Sci. USA 75, 3979-3983.
18. Conzelmann, E. & Sandhoff, K. 1979 Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. Hoppe-Seyler Z. Physiol. Chem. 360, 1837-1849.
19. Conzelmann, E., Burg, J., Stephan, G. & Sandhoff, K. 1982 Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Eur. J. Biochem. 123, 455-466.
20. Coste, H., Martel, M.-B. & Got, R. 1986 Topology of glucosylceramide synthesis in Golgi membranes from porcine sub-maxillary glands. Biochim. Biophys. Acta 858, 6-12.
21. Dickson, R. C. 1998 Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. A. Rev. Biochem. 67, 27-48.
22. Doering, T., Holleran, W. M., Potratz, A., Vielhaber, G., Elias, P. M., Suzuki, K. & Sandhoff, K. 1999a Sphingolipid activator proteins are required for epidermal permeability barrier formation. J. Biol. Chem. 274, 11 038-11 045.
23. Doering, T., Proia, R. L. & Sandhoff, K. 1999b Accumulation of protein-bound epidermal glucosylceramides in β-glucocerebrosidase deficient type 2 Gaucher mice. FEBS Lett. 447, 167-170.
24. Fabbro, D. & Grabowski, D. A. 1991 Human acid β-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites. J. Biol. Chem. 266, 15 021-15 027.
25. Fingerhut, R., Van der Horst, G. T., Verheijen, F. W. & Conzelmann, E. 1992 Degradation of gangliosides by the lysosomal sialidase requires an activator protein. Eur. J. Biochem. 208, 623-629.
26. Fischer, G. & Jatzkewitz, H. 1975 The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. Hoppe-Seyler Z. Physiol. Chem. 356, 605-613.
27. Fujimoto, H., Tadano-Aritomi, K., Tokumasu, A., Ito, K., Hikita, T., Suzuki, K. & Ishizuka, I. 2000 Requirement of seminolipid in spermatogenesis revealed by UDP-galactose: ceramide galactosyltransferase-deficient mice. J. Biol. Chem. 275, 22 623-22 626.
28. Fürst, W. & Sandhoff, K. 1992 Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim. Biophys. Acta 1126, 1-16.
29. Fürst, W., Machleidt, W. & Sandhoff, K. 1988 The precursor of sulfatide activator protein is processed to three different proteins. Biol. Chem. Hoppe-Seyler 369, 317-328.
30. Fürst, W., Schubert, J., Machleidt, W., Meyer, E. H. & Sandhoff, K. 1990 The complete amino-acid sequences of human ganglioside GM2-activator protein and cerebroside sulfate activator protein. Eur. J. Biochem. 192, 709-714.
31. Furukawa, K., Takamiya, K., Okada, M., Inoue, M., Fukumoto, S. & Furukawa, K. 2001 Novel functions of complex carbohydrates elucidated by the mutant mice of glycosyltransferase genes. Biochim. Biophys. Acta 1525, 1-12.
32. Futerman, A. H. 1994 An update of sphingolipid synthesis and transport along the secretory pathway. Trends Glycosci. Glycotechnol. 6, 143-153.
33. Futerman, A. H., Stieger, B., Hubbard, A. L. & Pagano, R. E. 1990 Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J. Biol. Chem. 265, 8650-8657.
34. Gärtner, S., Conzelmann, E. & Sandhoff, K. 1983 Activator protein for the degradation of globotriaosylceramide by human α-galactosidase. J. Biol. Chem. 258, 12 378-12 385.
35. Geeraert, L., Mannaerts, G. P. & Van Veldhoven, P. P. 1997 Conversion of dihydroceramide into ceramide: involvement of a desaturase. Biochem. J. 327, 125-132.
36. Giehl, A., Lemm, T., Bartelsen, O., Sandhoff, K. & Blume, A. 1999 Interaction of the GM2-activator protein with phospholipid-ganglioside bilayer membranes and with monolayers at the air-water interface. Eur. J. Biochem. 261, 650-658.
37. Gillard, B. K., Clement, R. G. & Marcus, D. M. 1998 Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways. Glycobiology 8, 885-889.
38. Giraudo, C. G., Rosales Fritz, V. M. & Maccioni, H. J. 1999 GA2/GM2/GD2 synthase localizes to the trans-golgi network of CHO-K1 cells. Biochem. J. 342, 633-640.
39. Giraudo, C. G., Daniotti, J. L. & Maccioni, H. J. F. 2001 Physical and functional association of glycolipid N-acetyl-galactosaminyl and galactosyl transferases in the Golgi apparatus. Proc. Natl Acad. Sci. USA 98, 1625-1630.
40. Haak, D., Gable, K., Beeler, T. & Dunn, T. 1997 Hydroxylation of Saccharomyces cerevisiae ceramides requires Sur2p and Scs7p. J. Biol. Chem. 272, 29 704-29 710.
41. Hakomori, S. 1981 Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. A. Rev. Biochem. 50, 733-764.
42. Hannun, Y. A. & Obeid, L. M. 2002 The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277, 25 847-25 850.
43. Harzer, K., Paton, B. C. & Poulos, A. 1989 Sphingolipid activator protein (SAP) deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling; biochemical signs of combined sphingolipidosis. Eur. J. Pediatr. 149, 31-39.
44. Henning, R. & Stoffel, W. 1973 Glycosphingolipids in lysosomal membranes. Hoppe-Seyler Z. Physiol. Chem. 354, 760-770.
45. Hepbildikler, S., Sandhoff, R., Kölzer, M., Proia, R. L. & Sandhoff, K. 2002 Physiological substrates for human lysosomal β-Hexosaminidase S. J. Biol. Chem. 277, 2562-2572.
46. Hidari, K., Kawashima, I., Tai, T., Inagaki, F., Nagai, Y. & Sanai, Y. 1994 In vitro synthesis of disialoganglioside (GD1 alpha) from asialo-GM1 using sialyltransferases in rat liver Golgi vesicles. Eur. J. Biochem. 221, 603-609.
47. Hiesberger, T., Hüttler, S., Rohlmann, A., Schneider, W., Sandhoffm, K. & Herz, J. 1998 Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP). EMBO J. 17, 4617-4625.
48. Hineno, T., Sano, A., Kondoh, K., Ueno, S., Kakimoto, Y. & Yoshida, K. 1991 Secretion of sphingolipid hydrolase activator precursor, prosaposin. Biochem. Biophys. Res. Commun. 176, 668-674.
49. Hiraiwa, M., Soeda, S., Kishimoto, Y. & O'Brien, J. S. 1992 Binding and transport of gangliosides by prosaposin. Proc. Natl Acad. Sci. USA 89, 11 254-11 258.
50. Hiraiwa, M., Taylor, E. M., Campana, W. M., Darin, J. S. & O'Brien, J. S. 1997 Cell death preventions, mitogen-activated protein kinase stimulation and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptide. Proc. Natl Acad. Sci. USA 94, 4778-4781.
51. Ho, M. W. & O'Brien, J. S. 1971 Gaucher's disease: deficiency of 'acid' β-glucosidase and reconstruction of enzyme activity in vitro. Proc. Natl Acad. Sci. USA 68, 2810-2813.
52. Honke, K. (and 10 others) 2002 Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc. Natl Acad. Sci. USA 99, 4227-4232.
53. Hulkova, H. (and 12 others) 2001 A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum. Mol. Genet. 10, 927-940.
54. Huwiler, A., Kolter, T., Pfeilschifter, J. & Sandhoff, K. 2000 Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 1485, 63-99.
55. Iber, H. 1988 Charakterisierung der GD1b-Synthase aus Rattenlebergogi - Inhibitionsstudien an der GA1-, GM1a-, GD1b-Synthase. Diploma thesis, Bonn University, Germany.
56. Iber, H., van Echten, G., Klein, R. A. & Sandhoff, K. 1990 pH-dependent changes of ganglioside biosynthesis in neuronal cell culture. Eur. J. Cell Biol. 52, 236-240.
57. Iber, H., Zacharias, C. & Sandhoff, K. 1992 The c-series gangliosides GT3, GT2 and GP1c are formed in rat liver Golgi by the same set of glycosyltransferases that catalyse the biosynthesis of asialo-, a- and b-series gangliosides. Glycobiol. 2, 137-142.
58. Ichikawa, S. & Hirabayashi, Y. 1998 Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 8, 198-202.
59. Ichikawa, S., Nakajo, N., Sakiyama, H. & Hirabayashi, Y. 1994 A mouse B16 melanoma mutant deficient in glycolipids. Proc. Natl Acad. Sci. USA 91, 2703-2707.
60. Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. & Hirabayashi, Y. 1996 Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl Acad. Sci. USA 93, 4638-4643.
61. Irie, F., Hidari, K. I., Tai, T., Li, Y. T., Seyama, Y. & Hirabayashi, Y. 1994 Biosynthetic pathway for a new series of gangliosides, GT1a alpha and GQ1b alpha. FEBS Lett. 351, 291-294.
62. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) 1998 Nomenclature of glycolipids. Recommendations 1997. Eur. J. Biochem. 257, 293-298.
63. Jeckel, D., Karrenbauer, A., Burger, K. N. J., Van Meer, G. & Wieland, F. 1992 Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J. Cell Biol. 117, 259-267.
64. Kapitonov, D. & Yu, R. K. 1999 Conserved domains of glycosyltransferases. Glycobiol. 9, 961-978.
65. Kaufman, B., Basu, S. & Roseman, S. 1968 Enzymatic synthesis of disialogangliosides from monosialogangliosides by sialyltransferases from embryonic chicken brain. J. Biol. Chem. 243, 5804-5807.
66. Kawai, H., Sango, K., Mullin, K. A. & Proia, R. L. 1998 Embryonic stem cells with a disrupted GD3 synthase gene undergo neuronal differentiation in the absence of b-series gangliosides. J. Biol. Chem. 273, 19 634-19 638.
67. Kawai, H. (and 11 others) 2001 Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J. Biol. Chem. 276, 6885-6888.
68. Kishimoto, Y., Hiraiwa, M. & O'Brien, J. S. 1992 Saposins: structure, function, distribution and molecular genetics. J. Lipid Res. 33, 1255-1267.
69. Klein, A., Henseler, M., Klein, C., Suzuki, K., Harzer, K. & Sandhoff, K. 1994 Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo. Biochem. Biophys. Res. Commun. 200, 1440-1448.
70. Klima, H., Tanaka, A., Schnabel, D., Suzuki, K. & Sandhoff, K. 1991 Characterization of full-length cDNA and the gene coding for the human GM2-activator protein. FEBS Lett. 289, 260-264.
71. Kobayashi, T., Strang, E., Fang, K., de Moerloose, P., Parton, R. G. & Gruenberg, J. 1998 A lipid associated with the anti-phospholipid syndrome regulates endosome structure and function. Nature 392, 193-237.
72. Kolter, T. & Sandhoff, K. 1999 Sphingolipids: their metabolic pathways and the pathobiochemistry of neurodegenerative diseases. Angew Chem. Int. Ed. 38, 1532-1568.
73. Kolter, T., Magin, T. & Sandhoff, K. 2000 Biomolecule function: no reliable prediction from cell culture. Traffic 1, 803-804.
74. Kolter, T., Proia, R. L. & Sandhoff, K. 2002 Minireview: combinatorial ganglioside biosynthesis. J. Biol. Chem. 277, 25 859-25 862.
75. Kondoh, K., Hineno, T., Sano, A. & Kakimoto, Y. 1991 Isolation and characterization of prosaposin from human milk. Biochem. Biophys. Res. Commun. 181, 286-292.
76. Kopitz, J. 1997 Glyoclipids: structure and function. In Glycosciences (ed. H. J. Gabius & S. Gabius), pp. 163-189. Wiley-VCh, Germany.
77. Kretz, K. A., Carson, G. S., Morimoto, S., Kishimoto, Y., Fluharty, A. L. & O'Brien, J. S. 1990 Characterization of mutation in a family with saposin B deficiency: a glycosylation site defect. Proc. Natl Acad. Sci. USA 87, 2541-2544.
78. Kytzia, H.-J. & Sandhoff, K. 1985 Evidence for two different active sites on human hexosaminidase A: interaction of GM2 activator protein with hexosaminidase. J. Biol. Chem. 260, 7568-7572.
79. Lannert, H., Gorgas, K., Meißner, I., Wieland, F. T. & Jeckel, D. 1996 Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi. J. Biol. Chem. 273, 2939-2946.
80. Lannert, H., Gorgas, K., Meißner, I., Wieland, F. T. & Jeckel, D. 1998 Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi. J. Biol. Chem. 273, 2939-2946.
81. Lapchak, P. A., Araujo, D. M., Shackelford, D. A. & Zivin, J. A. 2000 Prosaptide exacerbates ischemia-induced behavioral deficits in vivo: an effect that does not involve mitogen-activated protein kinase activation. Neuroscience 101, 811-814.
82. Ledeen, R. W. & Wu, G. 1992 Ganglioside function in the neuron. Trends Glycosci. Glycotechnol. 4, 174-187.
83. Ledeen, R. W., Yu, R. K. & Eng, L. F. 1973 Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component. J. Neurochem. 21, 829-839.
84. Li, J., Yen, T. Y., Allende, M. L., Joshi, R. K., Cai, J., Pierce, W. M., Jaskiewicz, E., Darling, D. S., Macher, B. A. & Young Jr, W. W. 2000 Disulfide bonds of GM2 synthase homodimers. Antiparallel orientation of the catalytic domains. J. Biol. Chem. 275, 41 476-41 486.
85. Liepinsh, E., Andersson, M., Ruysschaert, J. M. & Otting, G. 1997 Saposin fold revealed by the NMR structure of NK-lysin. Nature Struct. Biol. 10, 793-795.
86. Linke, T., Wilkening, G., Lansmann, S., Moczall, H., Bartelsen, O., Weisgerber, J. & Sandhoff, K. 2001a Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins. Biol. Chem. 382, 283-290.
87. Linke, T., Wilkening, G., Sadeghlar, F., Moczall, H., Bernardo, K., Schuchman, E. & Sandhoff, K. 2001b Interfacial regulation of acid ceramidase activity. J. Biol. Chem. 276, 5760-5768.
88. Liu, K., Commens, C., Choong, R. & Jaworski, R. 1988 Collodion babies with Gaucher's disease. Arch. Dis. Childhood 63, 854-856.
89. Liu, Y., Hoffmann, A., Grinberg, A., Westphal, H., McDonald, M. P., Miller, K. M., Crawley, J. N., Sandhoff, K., Suzuki, K. & Proia, R. L. 1997 Mouse model of GM2 activator deficiency manifests cerebellar ganglioside storage and motor impairment. Proc. Natl Acad. Sci. USA 94, 8138-8143.
90. Lloyd, K. O. & Furukawa, K. 1998 Biosynthesis and functions of gangliosides: recent advances. Glycoconjugate J. 15, 627-636.
91. Lutz, M. S., Jaskiewicz, E., Darling, D. S., Furukawa, K. & Young Jr, W. W. 1994 Cloned beta 1,4 N-acetylgalactosaminyltransferase synthesizes GA2 as well as gangliosides GM2 and GD2. GM3 synthesis has priority, over GA2 synthesis for utilization of lactosylceramide substrate in vivo. J. Biol. Chem. 269, 29 227-29 231.
92. Maccioni, H. J., Daniotti, J. L. & Martina, J. A. 1999 Organization of ganglioside synthesis in the Golgi apparatus. Biochim. Biophys. Acta 1437, 101-118.
93. Macheleidt, O., Kolter, T. & Sandhoff, K. 2003 Sphingolipid activator deficiencies and Niemann-Pick type C. In Lysosomal disorders of the brain (ed. F. Platt & S. U. Walkley). (In the press.)
94. Mahuran, D. J. 1998 The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein. Biochim. Biophys. Acta 1393, 1-18.
95. Mandon, E. C., van Echten, G., Birk, R., Schmidt, R. R. & Sandhoff, K. 1991 Sphingolipid biosynthesis in cultured neurons: down-regulation of serine palmitoyltransferase by sphingoid bases. Eur. J. Biochem. 198, 667-674.
96. Mandon, E. C., Ehses, I., Rother, J., van Echten, G. & Sandhoff, K. 1992 Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase and sphinganine N-acyltransferase in mouse liver. J. Biol. Chem. 267, 11 144-11 148.
97. Marsh, D. 1996 Lateral pressures in membranes. Biochim. Biophys. Acta 1286, 183-223.
98. Matsuda, J., Vanier, M. T., Saito, Y., Tohyama, J., Suzuki, K. & Suzuki, K. 2001 A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse. Hum. Mol. Genet. 10, 1191-1199.
99. Matsuzawa, Y. & Hostetler, K. Y. 1979 Degradation of bis(monoacylglycero)phosphate by an acid phosphodiesterase in rat liver lysosomes. J. Biol. Chem. 254, 5997-6001.
100. Mehl, E. & Jatzkewitz, H. 1964 Eine Cerebrosidsulfatase aus Schweineniere. Hoppe Seyler Z. Physiol. Chem. 339, 260-276.
101. Meier, E. M., Schwarzmann, G., Fürst, W. & Sandhoff, K. 1991 The human GM2 activator protein: a substrate specific cofactor of hexosaminidase A. J. Biol. Chem. 266, 1879-1887.
102. Merrill Jr, A. H. 2002 De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem. 277, 25 843-25 846.
103. Merrill Jr, A. H. & Wang, E. 1986 Biosynthesis of long-chain (sphingoid) bases from serine by LM cells. Evidence for introduction of the 4-trans-double bond after de novo biosynthesis of N-acylsphinganine(s). J. Biol. Chem. 261, 3764-3769.
104. Michel, C. & van Echten-Deckert, G. 1997 Conversion of dihydroceramide to ceramide occurs at the cytosolic face of the endoplasmic reticulum. FEBS Lett. 416, 153-155.
105. Michel, C., Van Echten-Deckert, G., Rother, J., Sandhoff, K., Wang, E. & Merrill Jr, A. H. 1997 Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J. Biol. Chem. 272, 22 432-22 435.
106. Mikami, T., Kashiwagi, M., Tsuchihashi, K., Akino, T. & Gasa, S. 1998 Substrate specificity and some other enzymatic properties of dihydroceramide desaturase (ceramide synthase) in fetal rat skin. J. Biochem. 123, 906-911.
107. Miro Obradors, J. M., Sillence, D., Howitt, S. & Allan, D. 1997 The subcellular sites of sphingomyelin synthesis in BHK cells. Biochim. Biophys. Acta 1359, 1-12.
108. Möbius, W., Herzog, V., Sandhoff, K. & Schwarzmann, G. 1999 Intracellular distribution of a biotin-labeled ganglioside GM1 by immunoelectron microscopy after endocytosis in fibroblasts. J. Histochem. Cytochem. 47, 1005-1014.
109. Morell, P. & Radin, N. S. 1970 Specificity in ceramide biosynthesis from long chain bases and various fatty acyl coenzyme A's by brain microsomes. J. Biol. Chem. 245, 342-350.
110. Morimoto, S., Martin, B. M., Kishimoto, Y. & O'Brien, J. S. 1988 Saposin D: a sphingomyelinase activator. Biochem. Biophys. Res. Commun. 156, 403-410.
111. Morimoto, S., Martin, B. M., Yamamoto, Y., Kretz, K. A. & O'Brien, J. S. 1989 Saposin A: second cerebrosidase activator protein. Proc. Natl Acad. Sci. USA 86, 3389-3393.
112. Morimoto, S., Kishimoto, Y., Tomich, J., Weiler, S., Ohashi, T., Barranger, J. A., Kretz, K. A. & O'Brien, J. S. 1990 Interaction of saposins, acidic lipids and glucosylceramidase. J. Biol. Chem. 265, 1933-1937.
113. Mundel, T. M., Heid, H. W., Mahuran, D. J., Kriz, W. & Mundel, P. 1999 Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells. J. Am. Soc. Nephrol. 10, 435-443.
114. Munford, R. S., Sheppard, P. O. & O'Hara, P. J. 1995 Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J. Lipid Res. 36, 1653-1663.
115. Nagiec, M. M., Baltisberger, J. A., Wells, G. B., Lester, R. L. & Dickson, R. C. 1994 The LCB2 gene of Saccharomyces and the related LCB1 gene encode subunits of serine palmitoyltransferase, the initial enzyme in sphingolipid synthesis. Proc. Natl Acad. Sci. USA 91, 7899-7902.
116. Nakamura, S.-I. (and 10 others) 1998 Requirement of GM2 ganglioside activator for phospholipase D activation. Proc. Natl Acad. Sci. USA 95, 12 249-12 253.
117. Nakano, T., Sandhoff, K., Stümper, J., Christomanou, H. & Suzuki, K. 1989 Structure of full length cDNA coding for sulfatide activator, a co-β glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator. J. Biochem. 105, 152-154.
118. Nakayama, J., Fukuda, M. N., Hirabayashi, Y., Kanamori, A., Sasaki, K., Nishi, T. & Fukuda, M. 1996 Expression cloning of a human GT3 synthase. GD3 AND GT3 are synthesized by a single enzyme. J. Biol. Chem. 271, 3684-3691.
119. Nomura, T. (and 11 others) 1998 Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1,4-galactosyltransferase from rat brain. J. Biol. Chem. 273, 13 570-13 577.
120. O'Brien, J. S., Kretz, K. A., Dewji, N., Wenger, D. A., Esch, F. & Fluharty, A. L. 1988 Coding of two sphingolipid activator proteins (SAP1 and SAP2) by same genetic locus. Science 241, 1098-1101.
121. Paul, P., Kamisaka, Y., Marks, D. L. & Pagano, R. E. 1996 Purification and characterization of UDP-glucose:ceramide glucosyltransferase from rat liver Golgi membranes. J. Biol. Chem. 271, 2287-2293.
122. Peters, C. & von Figura, K. 1994 Biogenesis of lysosomal membranes. FEBS Lett. 346, 108-114.
123. Pohlentz, G., Klein, D., Schwarzmann, G., Schmitz, D. & Sandhoff, K. 1988 Both GA2, GM2 and GD2 synthases and GM1b, GD1a and GT1b synthases are single enzymes in Golgi vesicles from rat liver. Proc. Natl Acad. Sci. USA 85, 7044-7048.
124. Ponting, C. P. & Russell, R. B. 1995 Swaposins: circular permutations within genes encoding saposin homologues. Trends Biochem. Sci. 20, 179-180.
125. Proia, R. L. 2003 Glycosphingolipid functions: insights from engineered mouse models. Phil. Trans. R. Soc. Lond. B 358, 879-883. (DOI 10.1098/rstb.2003.1268.)
126. Roseman, S. 1970 The synthesis of complex carbohydrates by multiglycosyltransferase systems and their potential function in intercellular adhesion. Chem. Phys. Lipids 5, 270-297.
127. Rother, J., van Echten, G., Schwarzmann, G. & Sandhoff, K. 1992 Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells. Biochem. Biophys. Res. Commun. 189, 14-20.
128. Salvioli, R., Tatti, M., Ciaffoni, F. & Vaccaro, A. M. 2000 Further studies on the reconstitution of glucosylceramidase activity, by Sap C and anionic phospholipids. FEBS Lett. 472, 17-21.
129. Sandhoff, K. 1977 The biochemistry of sphingolipid storage diseases. Angew Chem. Int. Ed. 16, 273-285.
130. Sandhoff, K. & Kolter, T. 1996 Topology of glycosphingolipid degradation. Trends Cell Biol. 6, 98-103.
131. Sandhoff, K., Harzer, K., Wässle, W. & Jatzkewitz, H. 1971 Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J. Neurochem. 18, 2469-2489.
132. Sandhoff, K., Kolter, T. & Harzer, K. 2001 Sphingolipid activator proteins. In The metabolic and molecular bases of inherited disease, vol 3, 8th edn (ed. C. R. Scriver, A. L. Beaudet, W. S. Sly & D. Valle), pp. 3371-3388. New York: McGraw-Hill.
133. Sarkar, S., Miwa, N., Kominami, H., Igarashi, N., Hayashi, S., Okada, T., Jahangeer, S. & Nakamura, S. 2001 Regulation of mammalian phospholipase D2: interaction with and stimulation by GM2 activator. Biochem. J. 359, 559-604.
134. Sarmientos, F., Schwarzmann, G. & Sandhoff, K. 1986 Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system. Eur. J. Biochem. 160, 527-535.
135. Schepers, U., Glombitza, G. J., Lemm, T., Hoffmann, A., Chabas, A., Ozand, P. & Sandhoff, K. 1996 Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB-variant. Am. J. Hum. Genet. 59, 1048-1056.
136. Schepers, U., Lemm, T., Herzog, V. & Sandhoff, K. 2000 Characterization of regulatory elements in the 5′-flanking region of the GM2 activator gene. Biol. Chem. 381, 531-544.
137. Schnabel, D., Schröder, M. & Sandhoff, K. 1991 Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett. 284, 57-59.
138. Schnabel, D. (and 11 others) 1992 Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J. Biol. Chem. 267, 3312-3315.
139. Schröder, M., Schnabel, D., Suzuki, K. & Sandhoff, K. 1991 A mutation in the gene of a glycolipid binding protein (GM2-activator) that causes GM2-gangliosidosis variant AB. FEBS Lett. 290, 1-3.
140. Schröder, M., Schnabel, D., Hurwitz, R., Young, E., Suzuki, K. & Sandhoff, K. 1993 Molecular genetics of GM2-gangliosidosis AB variant: a novel mutation and expression in BHK cells. Hum. Genet. 92, 437-440.
141. Schuette, C. G., Lemm, T., Glombitza, G. J. & Sandhoff, K. 1998 Complete localization of disulfide bonds in GM2-activator protein. Protein Sci. 7, 1039-1045.
142. Schuette, C. G., Pierstorff, B., Huettler, S. & Sandhoff, K. 2001 Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis. Glycobiology 11, 81R-90R.
143. Sheikh, K. A., Sun, J., Liu, Y., Kawai, H., Crawford, T. O., Proia, R. L., Griffin, J. W. & Schnaar, R. L. 1999 Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc. Natl Acad. Sci. USA 96, 7532-7537.
144. Shimeno, H., Soeda, S., Sakamoto, M., Kouchi, T., Kowakame, T. & Kihara, T. 1998 Partial purification and characterization of sphingosine N-acyltransferase (ceramide synthase) from bovine liver mitochondrion-rich fraction. Lipids 33, 601-605.
145. Smiljanic-Georgijev, N., Rigat, B., Leung, A. & Mahuran, D. J. 1997 Characterization of the affinity of the GM2 activator protein for glycolipids by a fluorescence dequenching assay. Biochim. Biophys. Acta 1339, 192-202.
146. Spiegel, S. & Milstien, S. 2002 Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277, 25 851-25 854.
147. Stern, C. A. & Tiemeyer, M. 2001 A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons. J. Neurosci. 21, 1434-1443.
148. Stern, C. A., Braverman, T. R. & Tiemeyer, M. 2000 Molecular identification, tissue distribution and subcellular localization of mST3GalV/GM3 synthase. Glycobiol. 10, 365-374.
149. Stoffel, W., LeKim, D. & Sticht, G. 1968 Metabolism of sphingosine bases. 8. Distribution, isolation and properties of D-3-oxosphinganine reductase. Stereospecificity of the NADPH-dependent reaction of 3-oxodihydrospingosine (2-amino-1-hydroxyoctadecane-3-one). Hoppe Seyler Z. Physiol. Chem. 349, 1637-1644.
150. Swallow, D. M., Islam, I., Fox, M. F., Povey, S., Klima, H., Schepers, U. & Sandhoff, K. 1993 Regional localisation of the gene coding for the GM2 activator protein (GM2A) to chromosome 5q32-33 and confirmation of the assignment of GM2AP to chromosome 3. Ann. Hum. Genet. 57, 187-193.
151. Tagami, S. (and 11 others) 2002 Ganglioside GM3 participates in the pathological conditions of insulin resistance. J. Biol. Chem. 277, 3085-3092.
152. Takamiya, K. (and 14 others) 1996 Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl Acad. Sci. USA 93, 10 662-10 667.
153. Takamiya, K. (and 12 others) 1998 Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. Proc. Natl Acad. Sci. USA 95, 12 147-12 152.
154. Tayama, M., Soeda, S., Kishimoto, Y., Martin, B. M., Callahan, J. W., Hiraiwa, M. & O'Brien, J. S. 1993 Effects of saposins on acid sphingomyelinase. Biochem. J. 290, 401-404.
155. Vaccaro, A. M., Ciaffoni, F., Tatti, M., Salvioli, R., Barca, A., Tognozzi, D. & Scerch, C. 1995a pH-dependent conformational properties of saposins and their interactions with phospholipid membranes. J. Biol. Chem. 270, 30 576-30 580.
156. Vaccaro, A. M., Salvioli, R., Barca, A., Tatti, M., Ciaffoni, F., Maras, B., Siciliano, R., Zappacosta, F., Amoresano, A. & Pucci, P. 1995b Structural analysis of saposin C and B. Complete localization of disulfide bridges. J. Biol. Chem. 270, 9953-9960.
157. Vaccaro, A. M., Tatti, M., Ciaffoni, F., Salvioli, R., Barca, A. & Scerch, C. 1997 Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide. J. Biol. Chem. 272, 16 862-16 867.
158. Vaccaro, A. M., Salvioli, R., Tatti, M. & Ciaffoni, F. 1999 Saposins and their interactions with lipids. Neurochem. Res. 24, 307-314.
159. Van der Goot, F. G. & Gruenberg, J. 2002 Oiling the wheels of the endocytic pathway. Trends Cell Biol. 12, 296-299.
160. van Echten, G. & Sandhoff, K. 1993 Ganglioside metabolism: enzymology, topology and regulation, minireview. J. Biol. Chem. 268, 5341-5344.
161. van Echten, G., Birk, R., Brenner-Weiß, G., Schmidt, R. R. & Sandhoff, K. 1990 Modulation of sphingolipid biosynthesis in primary cultured neurons by long-chain bases. J. Biol. Chem. 265, 9333-9339.
162. Van Meer, G. & Lisman, Q. 2002 Sphingolipid transport: rafts and translocators. J. Biol. Chem. 277, 25 855-25 858.
163. Vielhaber, G., Hurwitz, R. & Sandhoff, K. 1997 Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP-) precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP-precursor. J. Biol. Chem. 271, 32 438-32 446.
164. Vogel, A., Schwarzmann, G. & Sandhoff, K. 1991 Glycosphingolipid specificity of the human sulfatide activator protein. Eur. J. Biochem. 200, 591-597.
165. Warnock, D. E., Lutz, M. S., Blackburn, W. A., Young, W. W. & Baenziger, J. U. 1994 Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway. Proc. Natl Acad. Sci. USA 91, 2708-2712.
166. Watanabe, R., Wu, K., Paul, P., Marks, D. L., Kobayashi, T., Pittelkow, M. R. & Pagano, R. E. 1998 Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation. J. Biol. Chem. 273, 9651-9655.
167. Weiss, B. & Stoffel, W. 1997 Human and murine serine-palmitoyl-CoA transferase - cloning, expression and characterization of the key enzyme in sphingolipid synthesis. Eur. J. Biochem. 249, 239-247.
168. Wenger, D. A., Sattler, M. & Roth, S. 1982 A protein activator of galactosylceramide-β-galactosidase. Biochim. Biophys. Acta 712, 639-649.
169. Werth, N., Schuette, C. G., Wilkening, G., Lemm, T. & Sandhoff, K. 2001 Degradation of membrane-bound ganglioside GM2 by β-hexosaminidase A. J. Biol. Chem. 276, 12 685-12 690.
170. Wertz, P. W. & Downing, D. T. 1987 Covalently bound omega-hydroxyacylsphingosine in the stratum corneum. Biochim. Biophys. Acta 917, 108-111.
171. Wertz, P. W. & Van den Bergh, B. 1998 The physical, chemical and functional properties of lipids in the skin and other biological barriers. Chem. Phys. Lipids 91, 85-96.
172. Wilkening, G., Linke, T. & Sandhoff, K. 1998 Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J. Biol. Chem. 273, 30 271-30 278.
173. Wilkening, G., Linke, T., Uhlhorn-Dierks, G. & Sandhoff, K. 2000 Degradation of membrane-bound ganglioside GM1. J. Biol. Chem. 275, 35 814-35 819.
174. Wright, C., Li, S.-C. & Rastinejad, F. 2000 Crystal structure of human GM2-activator protein with a novel β-cup topology. J. Mol. Biol. 304, 411-422.
175. Wrobe, D., Henseler, M., Huettler, S., Pascual Pascual, S. I., Chabas, A. & Sandhoff, K. 2000 A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD). J. Inherit. Metab. Dis. 23, 63-76.
176. Wu, Y. Y., Lockyer, J. M., Sugiyama, E., Pavlova, N. V., Li, Y.-T. & Li, S.-C. 1994 Expression and specifity of human GM2-activator protein. J. Biol. Chem. 269, 16 276-16 283.
177. Wu, Y. Y., Sonnino, S., Li, Y.-T. & Li, S.-C. 1996 Characterization of an alternatively spliced GM2 activator protein, GM2A protein. An activator protein which stimulates the enzymatic hydrolysis of N-acetylneuraminic acid, but not N-acetylgalactosamine, from GM2. J. Biol. Chem. 271, 10611-10615.
178. Xie, B., Kennedy, J. L., McInnes, B., Auger, D. & Mahuran, D. 1992 Identification of a processed pseudogene related to the functional gene encoding the GM2 activator protein: localization of the pseudogene to human chromosome 3 and the functional gene to human chromosome 5. Genomics 14, 796-798.
179. Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K. & Proia, R. L. 1999 A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl Acad. Sci. USA. 96, 9142-9147.
180. Yip, M. C. M. & Dain, J. A. 1969 The enzymic synthesis of ganglioside. 1. Brain uridine diphosphate D-galactose: N-acetyl-galactosaminyl-galactosyl-glucosyl-ceramide galactosyl transferase. Lipids 4, 270-277.
181. Young, W. W., Allende, M. L. & Jaskiewicz, W. 1999 Reevaluating the effect of Brefeldin A (BFA) on ganglioside synthesis: the location of GM2 synthase cannot be deduced from the inhibition of GM2 synthesis by BFA. Glycobiol. 9, 689-695.
182. Yusuf, H., Schwarzmann, G., Pohlentz, G. & Sandhoff, K. 1987 Oligosialogangliosides inhibit GM2- and GD3-synthesis in isolated Golgi vesicles from rat liver. Biol. Chem. 368, 455-462.
183. Zaltash, S. & Johansson, J. 1998 Secondary structure and limited proteolysis give experimental evidence that the precursor of pulmonary surfactant protein B contains three saposin-like domains. FEBS Lett. 423, 1-4.
184. Zhao, V., Beeler, V. & Dunn, V. 1994 Suppressors of the Ca(2+)-sensitive yeast mutant (csg2) identify genes involved in sphingolipid biosynthesis. Cloning and characterization of SCS1, a gene required for serine palmitoyltransferase activity. J. Biol. Chem. 34, 21 480-21 488.
185. Zhao, J., Furukawa, K., Fukumoto, S., Okada, M., Furugen, R., Miyazaki, H., Takamiya, K., Aizawa, S., Shiku, H., Matsuyama, T. & Furukawa, K. 1999 Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice. J. Biol. Chem. 274, 13 744-13 747.
186. Zschoche, A., Fürst, W., Schwarzmann, G. & Sandhoff, K. 1994 Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-β-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Eur. J. Biochem. 222, 83-90.